Product Images Rhogam Ultra-filtered Plus

This is a notice for laboratory staff in a hospital regarding the administration of Rhg(D) immune globulin (Human) RhoGAM® and MICRhoGAM® Ultra-Filtered PLUS. The notice includes important instructions for verifying patient identification, lot number, expiration date of the product, and the patient's Rho(D) type before administering the single dose injection. Additionally, the form includes spaces for recording results of a FMH screening test and the date and indication for the injection administration, as well as space for the attending physician's details.*

This document appears to be a form or instruction set for administering the RhoGAM® and MICRhoGAM® Ultra-Filtered PLUS products, which are immune globulins used for Rh-negative pregnant women. Before administering the medication, the patient's identification and the lot number and expiration date of the product must be verified. The form also includes space to record relevant medical information, such as the timing of injection, FMH screening test results, and delivery status. This information can be used to verify that RhoGAM/MICRhoGAM was administered properly.*

This appears to be a form used in a hospital for the administration of RhoGAM and MICRhoGAM vaccines to Rh negative patients who are carrying Rh positive or unknown type of baby. The form includes fields for patient and hospital information along with details such as lot number and expiration date of the vaccine. The form also recommends verifying the information printed on the prefilled syringe with the information provided on the form before administering the vaccine. The form needs to be retained as proof of vaccine administration. The form also mentions the different indications and timing for the administration of the vaccine as well as the attending physician.*

This is a medication called RhoGAM Ultra-Filtered PLUS used to prevent hemolytic disease of the newborn in pregnant women who are Rh-negative. It is a human immunoglobulin that helps prevent the mother's immune system from attacking the baby's red blood cells. The package includes a 300 microgram (1500 IU) dose and the manufacturer is Kedrion Biopharma Inc. located in Melville, NY. It is sold under the US License 1906 and the NDC number is 0562-7805-00.*

This is a product description for RhoGAM, a Rho(D) Immune Globulin injection used to prevent Hemolytic disease of the newborn in women with Rh negative blood. The pouch is tamper-resistant and sealed, and the injection is ultra-filtered for safety. It is a 300 pg dose (1500 IU*) injection and comes with a Thimerosal-Free and Latex-Free Delivery System. Patients and their physicians should discuss the risks and benefits of this product. The package contains directions for use and the manufacturer's name and address. The National Drug Code (NDC) for this injection is 0562-7805-00.*

This is a package of Rho(D) Immune Globulin (Human) AP RESETANT called RhoGAM. It contains a 300 pg dose (1500 IU*) for delivering intramuscularly. The delivery system of the dose is latex-free. The product is manufactured by Kedrion Biopharma in the USA, and the package is RX only. The package has a specific direction for use by the patient and physician, and they should consider its risks and benefits before usage.*

RhoGAM Ultra-Filtered PLUS is a type of Rho(D) Immune Globulin (Human) that comes in a package containing an Active ingredient which is a pre-filled syringe containing 300 ug Dose (1500 IU*) of Ant-D A Immune Globulin, determined according to the US/WHO/EP Standard. The package also includes a package insert, a single-dose ampule of Rho(D) immune Globulin (Human), a patient identification card, and some inactive ingredient such as sodium chloride and polysorbate 80. It is manufactured by Kedrion Biopharm in New York, USA. No further information is available in the provided text.*

RhoGAM® is an Ultra-Filtered PLUS Thimerosal-Free Rho(D) Immune Globulin (Human) medication, with a 300 g Dose (1500 IU*), that is not suitable for unsensitized negative women or infants who are dairy and/or fan positive. It is important not to let infants have it. The text includes some legal and manufacturing information.*

Rho(D) Immune Globulin (Human) named RhoGAM is a Thimerosal-Free injection used for intramuscular use only. The recommended dose is 300 µg which contains 1500 IU Ultra-Filtered PLUS. The product is available in vials with NDC 0562-7805-25. The physician and patient should discuss the benefits and risks of the product before use. The remaining text is not available or readable.*

This is a description for Rho(D) Immune Globulin (Human) in a 50g dose called MICRhoGAM® Ultra-Filtered PLUS by KEDRION BIOPHARMA INC. The direction for use is provided and it states that it is used for U.S. LICENSE 1906. The NDC number is available as well.*

This is a packaging label for Rho(D) Immune Globulin (Human) which is represented by the brand name MICRhoGAM®. The product comes in a 50 ig dose (250 IU*) and is Thimerosal-Free and has a Latex-Free Delivery System. It is intended for use under prescription only and the instructions for use are provided in the package. The label also warns to discuss the risks and benefits of the product with a physician prior to use.*

This seems to be a product information document that includes a description of Rhg(D) and Rho(D) immune globulin (human) produced by Kedrion Biopharm. The document provides information about the dosage, filtering process, potential side effects, and instructions for use. It mentions the brand name MICRhoGAM® and its use for preventing spontaneous or induced abortion in pregnant women. There is also some unreadable text and an overlapped area that obstructs the content.*

This is a product description for Rhg(D) Immune Globulin (Human) - MICRhoGAM, a medication used to prevent hemolytic disease of the newborn. It is available as an ultra-filtered injection in a 50 g dose without thimerosal and should not be injected intravenously. The text includes dosage information, manufacturer details, and warnings.*